Publications by authors named "William Gerth"

Claim this Profile
ï
Lateral and longitudinal dispersal of aquatic insects in mountain streams, with notes about Trichoptera.
Tatiana Latorre-Beltrán, Ivan Arismendi, Blanca Rios-Touma, William Joseph Gerth, Alexander Petty

Zookeys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for infection influencing survival of the freshwater copepod Salmincola californiensis, a parasite of Pacific salmon and trout.
Christina A Murphy, William Gerth, Travis Neal, Kelsi Antonelli, Justin L Sanders

J Aquat Anim Health· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hatching and survival of the salmon 'gill maggot' (Copepoda: Lernaeopodidae) reveals thermal dependence and undocumented naupliar stage.
Christina A Murphy, William Gerth, Ivan Arismendi

Parasitology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of the exotic tick Hyalomma truncatum on a human with travel to Ethiopia: a case report.
Blaine A Mathison, William J Gerth, Bobbi S Pritt, Stephen Baugh

Ticks Tick Borne Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada.
William C Gerth, Stephen D Betschel, Arthur S Zbrozek

Allergy Asthma Clin Immunol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating vertebrate, benthic macroinvertebrate, and diatom taxa richness in raftable Pacific Northwest rivers for bioassessment purposes.
Robert M Hughes, Alan T Herlihy, William J Gerth, Yangdong Pan

Environ Monit Assess· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
John R Wingard, Helen L Leather, Craig A Wood, William C Gerth, Robert J Lupinacci

Am J Health Syst Pharm· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy.
George W Carides, Shahnaz Shahinfar, Erik J Dasbach, William F Keane, William C Gerth

Pharmacoeconomics· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
Andrew J Ullmann, Miguel A Sanz, Andrea Tramarin, Rosemary A Barnes, Wenchen Wu, William C Gerth

Clin Infect Dis· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes in patients receiving conventional amphotericin B therapy: a prospective multicentre study in Taiwan.
Chien-Yuan Chen, Ritesh N Kumar, Yin-Hsun Feng, Chao-Hung Ho, Jie-Yu You, William C Gerth

J Antimicrob Chemother· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
D Tony Yu, Josh F Peterson, Diane L Seger, William C Gerth, David W Bates

Pharmacoepidemiol Drug Saf· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis.
John R Wingard, Craig A Wood, Elizabeth Sullivan, Marc L Berger, William C Gerth

Clin Ther· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?
Hans-Georg Eichler, Sheldon X Kong, William C Gerth, Panagiotis Mavros, Bengt Jönsson

Value Health· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
Ellen D Burgess, George W Carides, William C Gerth, Michael A Marentette, Isabelle Chabot

Can J Cardiol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of hospitalization of patients with Candida and Aspergillus infections in Australia.
Monica Slavin, John Fastenau, Isaya Sukarom, Panagiotis Mavros, Steven Crowley, William C Gerth

Int J Infect Dis· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
William C Gerth, Syam Sarma, X Henry Hu, Stephen D Silberstein

J Occup Environ Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential economic consequences of cognitive improvement with losartan.
Linus Jönsson, William Gerth, Johan Fastbom

Blood Press· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation.
William H Herman, Shahnaz Shahinfar, George W Carides, Erik J Dasbach, William C Gerth

Diabetes Care· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.
Jean Lambert, George W Carides, Jacques P Meloche, William C Gerth, Michael A Marentette

Can J Clin Pharmacol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.
William C Gerth, Giuseppi Remuzzi, GianCarlo Viberti, Thierry Hannedouche, Alberto Martinez-Castelao

Kidney Int Suppl· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compliance and persistence with newer antihypertensive agents.
William C Gerth

Curr Hypertens Rep· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
Gennaro Bussone, Domenico D'Amico, Kathleen A McCarroll, William Gerth, Christopher R Lines

Eur Neurol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihypertensive persistence and drug class.
Michael A Marentette, William C Gerth, David K Billings, Kelly B Zarnke

Can J Cardiol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis